Clinical Trial Update: Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics [NA]

View source ↗

Summary

A completed clinical trial assessing breast cancer patients using dynamic contrast-enhanced MRI, magnetic resonance spectroscopy, and proteomic analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED